Abstract
The objective of this retrospective comparative study was to improve the outcome of patients with suspected occult Candida infection after gastrointestinal surgery by early presumptive therapy. It was conducted in the National Cheng Kung University Hospital in Taiwan. A total of 36 patients with prolonged ileus with fever after gastrointestinal tract surgery between January 1995 and December 2002 were examined for two time periods: those treated before and those treated after January 1999. One set of patients did not receive early presumptive therapy (EPT) until Candida infection was confirmed, and they were designated EPT(−). Another group of patients with suspected occult Candida infection received EPT and were designated EPT(+). Fluconazole, 400 mg/day, was given as EPT. Urine, wound, intraperitoneal drainage, and blood specimens were obtained from patients for fungus culture before starting treatment and weekly until symptoms subsided. The primary endpoints were the frequency of candidiasis and the persistence of candidemia; the secondary endpoint was the efficiency of EPT in the clinical outcome. There was no difference in Candida peritonitis, wound colonization, or urine colonization in the two treatment groups. Candida albicans accounted for 87.5%% of the isolated Candida species: 84.6%% in the EPT(+) group and 89.5%% in the EPT(−) group. In the EPT(+) group, the positive blood culture rate was 66.7%%. The fever subsided rapidly in 17 patients (94%%), the hospital stay and intensive care unit stay were shorter, and the mortality decreased significantly: 11%% vs. 78%%, P < 0.001. Persistent gastrointestinal ileus was the main cause of breakthrough candidemia. We concluded that EPT with fluconazole improves the prognosis of patients with occult Candida infection after gastrointestinal surgery. Surgical intervention was required in patients with breakthrough candidemia.
Similar content being viewed by others
References
Banerjee SN, Emori TG, Culver DH et al. Secular trends in nosocomial primary blood-stream infections in the United States, 1980–1989. Am J Med 1989;91(Suppl. 3B):86S–89S
Beck-Sague CM, Jarvis WR, National Nosocomial Infections Surveillence System: secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis 1993;167:1247–1251
Wey SB, Mori M, Pfaller MA, et al. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642–2645
Solomkin JS, Flohr AM, Simmons RL. Indications for therapy for fungemia in postoperative patients. Arch Surg 1982;117:1272–1275
Pittet D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751–758
Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract: the “undrained abscess” of multiple organ failure. Ann Surg 1993;218:111–119
Stone HH, Kolb LD, Currie CA, et al. Candida sepsis: pathogenesis and principles of treatment. Ann Surg 1974;179:697–711
Volkheimer G, Schultz FH. The phenomenon of persorption. Digestion 1968;1:213–218
Stone HH, Geheber CE, Kolb LD, et al. Alimentary tract colonization by Candida albicans. J Surg Res 1973;14:273–276
Dean DA, Burchard KW. Surgical perspective on invasive Candida infection. World J Surg 1998;22:127–134
Rex JH, Walsh TJ, Sobel JD, et al. Practice guideline for the treatment of candidiasis. Clin Infect Dis 2000;30:662–678
Solomkin JS, Flohr A, Simmons RL. Candida infection in surgical patients: does requirements and toxicity of amphotericin B. Ann Surg 1981;195:177–185
Eubanks PJ, de Virgilio C, Klein S, et al. Candida sepsis in surgical patients. Am J Surg 1993;166:617–620
Marsh PK, Tally FP, Kellum J, et al. Candida infections in surgical patients. Ann Surg 1983;198:42–47
Burchard KW, Minor LB, Slotman GJ, et al. Fungal sepsis in surgical patients. Arch Surg 1983;118:217–221
Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida kruzei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1992;325:1274–1277
Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325–1330
Nassoura Z, Ivatury RR, Simon RJ, et al. Candidiuria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J Trauma 1993;35:290–295
Edwards JE, Filler SG. Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients. Clin Infect Dis 1992;14(Suppl. 1):106–113
Edwards JE Jr, Bodey GP, Bowden RA, et al. International conference for the development of a consensus on the management and prevention of severe candidal infection. Clin Infect Dis 1997;25:43–49
Edward JE Jr, Drutz DJ, Bennett JE, et al. Disseminated Candidasis: a Major Problem in Cancer and Postoperative Patients, New York, Academy Professional Information Services, 1986
Woods GL, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, et al (eds). Manual of Clinical Microbiology, 6th edition, Washington DC, American Society for Microbiology Press, 1995;pp 1327–1341
Eggimann P, Francioli P, Bille J, et al. Fluconazole prophylaxis prevents intraabdominal candidiasis in high-risk surgical patients. Crit Care Med 1999;27:1066–1072
Calandra T, Bille J, Schneider R, et al. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989;2:1437–1440
Blumberg EA, Reboli AC. Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer. Clin Infect Dis 1996;22:462–466
Eras P, Goldstein M, Sherlock P. Candida infection of the gastrointestinal tract. Medicine (Baltimore) 1972;51:367–379
Chang T, Lu R, Tsai L. Glutamine ameliorates mechanical obstruction-induced intestinal injury. J Surg Res 2001;95:133–140
Prabhu R, Anup R, Balasubramanian KA. Surgical stress induces phospholipid degradation in the intestinal brush border membrane. J Surg Res 2000;94:178–184
Bayer AD, Blumenkrantz MJ, Montgomerie JZ, et al. Candida peritonitis: report of 22 cases and review of the English literature. Am J Med 1976;61:832–840
Savino JA, Agarwal N, Wry P, et al. Route prophylactic antifungal agents (clotrimazole, ketoconazole, and ny0statin) in nontransplant/nonburned critically ill surgical and trauma patients. J Trauma 1994;36:20–26
Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infection in patients undergoing bone marrow transplantation. N Engl J Med 1992;326:845–851
Ghannoum MA, Rex JH, Galgiani JN. Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J Clin Microbiol 1996;34:489–495
Ersin S, Tuncyurek P, Esassolak M, et al. The prophylactic and therapeutic effects of glutamine- and arginine-enriched diets on radiation-induced enteritis in rats. J Surg Res 2000;89:121–125
Ward DT, Lawson SA, Gallagher CM, et al. Sustained nitric oxide production via l-arginine administration ameliorates effects of intestinal ischemia-reperfusion. J Surg Res 2000;89:13–19
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shan, YS., Sy, E.D., Wang, ST. et al. Early Presumptive Therapy with Fluconazole for Occult Candida Infection after Gastrointestinal Surgery. World J. Surg. 30, 119–126 (2006). https://doi.org/10.1007/s00268-005-7807-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-005-7807-z